Registration
Register for Cleveland Clinic’s Comprehensive Cancer Center Medical Oncology Update 2025 on Wednesday June 18 at the Intercontinental Hotel and Conference Center in Cleveland OH
Related Articles
Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy | JCO Oncology Practice
In this issue of JCO Oncology Practice, Majhail et al 1 describe their organization’s experience with outpatient chimeric antigen receptor T-cell (CAR-T) cell therapy using…
From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s
Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for…
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly…
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly…
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients | JCO Oncology Practice
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly…
Are Your Patients With Cancer Experiencing Sexual Dysfunction? Just Ask!
The majority of patients with all cancer types face some type of sexual dysfunction.
Are Your Patients With Cancer Experiencing Sexual Dysfunction? Just Ask!
The majority of patients with all cancer types face some type of sexual dysfunction.
Cleveland Cavaliers vs Miami Heat Apr 26, 2025 Game Summary
Cleveland Cavaliers vs Miami Heat Apr 26, 2025 game result including recap, highlights and game information
Akeso wins Chinese approval for cancer drug positioned to rival Merck’s Keytruda
An Akeso lung cancer drug that beat Merck’s Keytruda in a head-to-head trial won approval in China this week